Steinacker et al. reported that patients with ALS and FTD had higher TDP-43 levels than controls in CSF, which indicated that CSF TDP-43 might aid in characterizing the subgroups of patients across the ALS and FTD disease spectrum (6). Here, TARDBP is linked to amyotrophic lateral sclerosis.